UnitedHealth's CEO Stephen Hemsley addresses investor concerns amid rising medical costs, regulatory investigations, and operational challenges affecting the insurer's 2025 earnings forecast and market confidence.

SBI Life Insurance reported strong Q1 results with 12% growth in value of new business and improved VNB margins, supported by stable bancassurance and positive market outlook from major analysts.

SBI Life Insurance's Q1 FY26 results reveal a strategic product mix shift driving VNB margin growth amid cost discipline and regulatory vigilance in India's insurance sector.

HCA Healthcare's Q2 2024 earnings demonstrate strategic growth fueled by digital transformation, aging demographics, and expansion into non-acute care. Strong financial metrics and operational discipline highlight market leadership.

Explore why Lincoln National, Lemonade, and AXIS Capital stocks require caution in portfolios amid market gains and risk exposures in the insurance sector.

Explore how Marsh & McLennan Companies leverages diversification and acquisitions to maintain growth and profitability amid softening insurance pricing and rising liability costs.

Clover Health launches a New Jersey pharmacy pilot targeting medication adherence and hospitalization cuts to improve Medicare Advantage margins and unlock growth potential.

Lemonade expands into Indiana's $5B auto insurance market leveraging AI, telematics, and bundling strategies to drive premium growth and approach profitability by 2026.

Centene's financial guidance withdrawal due to rising costs causes a 40% stock drop, impacting the health insurance sector and investor confidence.

Ategrity Specialty Holdings initiates IPO priced $14-$16 per share to bolster capital and expand specialty P&C insurance operations, reporting strong net income growth for 2024.